|
[1]LANCELLOTTI S,BASSO M,de CRISTOFARO R.Proteolytic processing of von Willebrand factor by adamts13 and leukocyte proteases[J].Mediterr J Hematol Infect Dis,2013,5(1):e2013058.
|
|
[2]ZHENG XL.Structure-function and regulation of ADAMTS-13protease[J].J Thromb Haemost,2013,11(Suppl 1):11-23.
|
|
[3]de GROOT R,LANE DA,CRAWLEY JT.The role of the ADAMTS13 cysteine-rich domain in VWF binding and proteolysis[J].Blood,2015,125(12):1968-1975.
|
|
[4]QU L,JIANG M,QIU W,et al.Assessment of the diagnostic value of plasma levels,activities,and their ratios of von Willebrand factor and ADAMTS13 in patients with cerebral infarction[J].Clin Appl Thromb Hemost,2015.[Epub ahead of print]
|
|
[5]UEMURA M,FUJIMURA Y,MATSUMOTO M,et al.Comprehensive analysis of ADAMTS13 in patients with liver cirrhosis[J].Thromb Haemost,2008,99(6):1019-1029.
|
|
[6]LISMAN T,BONGERS TN,ADELMEIJER J,et al.Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity[J].Hepatology,2006,44(1):53-61.
|
|
[7]KIM W,KIM DJ.Severe alcoholic hepatitis-current concepts,diagnosis and treatment options[J].World J Hepatol,2014,6(10):688-695.
|
|
[8]UEMURA M,MATSUYAMA T,ISHIKAWA M,et al.Decreased activity of plasma ADAMTS13 may contribute to the development of liver disturbance and multiorgan failure in patients with alcoholic hepatitis[J].Alcohol Clin Exp Res,2005,29(12 Suppl):264s-271s.
|
|
[9]MATSUYAMA T,UEMURA M,ISHIKAWA M,et al.Increased von Willebrand factor over decreased ADAMTS13 activity may contribute to the development of liver disturbance and multiorgan failure in patients with alcoholic hepatitis[J].Alcohol Clin Exp Res,2007,31(1 Suppl):s27-s35.
|
|
[10]ISHIKAWA M,UEMURA M,MATSUYAMA T,et al.Potential role of enhanced cytokinemia and plasma inhibitor on the decreased activity of plasma ADAMTS13 in patients with alcoholic hepatitis:relationship to endotoxemia[J].Alcohol Clin Exp Res,2010,34(Suppl 1):s25-s33.
|
|
[11]UEMURA M,FUJIMURA Y,KO S,et al.Determination of ADAMTS13 and its clinical significance for ADAMTS13 supplementation therapy to improve the survival of patients with decompensated liver cirrhosis[J].Int J Hepatol,2011,2011:759047.
|
|
[12]CAO WJ,NIIYA M,ZHENG XW,et al.Inflammatory cytokines inhibit ADAMTS13 synthesis in hepatic stellate cells and endothelial cells[J].J Thromb Haemost,2008,6(7):1233-1235.
|
|
[13]BOCKMEYER CL,CLAUS RA,BUDDE U,et al.Inflammationassociated ADAMTS13 deficiency promotes formation of ultra-large von Willebrand factor[J].Haematologica,2008,93(1):137-140.
|
|
[14]CHEUK DK.Hepatic veno-occlusive disease after hematopoietic stem cell transplantation:prophylaxis and treatment controversies[J].World J Transplant,2012,2(2):27-34.
|
|
[15]PARK YD,YOSHIOKA A,KAWA K,et al.Impaired activity of plasma von Willebrand factor-cleaving protease may predict the occurrence of hepatic veno-occlusive disease after stem cell transplantation[J].Bone Marrow Transplant,2002,29(9):789-794.
|
|
[16]MATSUMOTO M,KAWA K,UEMURA M,et al.Prophylactic fresh frozen plasma may prevent development of hepatic VOD after stem cell transplantation via ADAMTS13-mediated restoration of von Willebrand factor plasma levels[J].Bone Marrow Transplant,2007,40(3):251-259.
|
|
[17]NWABA A,MacQ UILLAN G,ADAMS LA,et al.Tacrolimus-induced thrombotic microangiopathy in orthotopic liver transplant patients:case series of four patients[J].Intern Med J,2013,43(3):328-333.
|
|
[18]TAKAHASHI N,WADA H,USUI M,et al.Behavior of ADAMTS13 and von Willebrand factor levels in patients after living donor liver transplantation[J].Thromb Res,2013,131(3):225-229.
|
|
[19]NAKAZAWA Y,HASHIKURA Y,URATA K,et al.Von Willebrand factor-cleaving protease activity in thrombotic microangiopathy after living donor liver transplantation:a case report[J].Liver Transpl,2003,9(12):1328-1333.
|
|
[20]KATO S,MATSUMOTO M,MATSUYAMA T,et al.Novel monoclonal antibody-based enzyme immunoassay for determining plasma levels of ADAMTS13 activity[J].Transfusion,2006,46(8):1444-1452.
|
|
[21]PEREBOOM IT,ADELMEIJER J,van LEEUWEN Y,et al.Development of a severe von Willebrand factor/ADAMTS13 dysbalance during orthotopic liver transplantation[J].Am J Transplant,2009,9(5):1189-1196.
|
DownLoad: